COVID-19: FDA Revokes Its Umbrella EUA For Infusion Pumps And Their Accessories
The revocation was made to “protect the public health,” the agency’s chief scientist says in letter
The US agency has revoked an umbrella emergency use authorization for infusion pumps and their accessories that it issued in mid-May.
You may also be interested in...
Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.
The US agency has announced four more webinars aimed at labs and manufacturers that are (or have) developed diagnostic tests for the novel coronavirus.
The US FDA’s list of essential products for use during infectious diseases outbreaks and other public health threats comes almost three months after President Trump signed an executive order directing the agency to develop one.